FDA approval for Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) for subcutaneous injection – BMS
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig, Bristol Myers Squibb Company) for subcutaneous injection across approved adult, solid tumor nivolumab (Opdivo, Bristol Myers Squibb Company) indications… read more.
